| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.322.543 | 5.629.824 | 7.708.972 | 9.288.006 | 11.251.721 | 11.904.964 | 18.596.992 | 19.257.639 | 22.349.497 | 25.573.055 |
| Total Income - EUR | 4.445.233 | 5.744.875 | 7.775.288 | 9.360.607 | 11.364.466 | 12.279.742 | 18.885.018 | 20.154.510 | 22.862.612 | 26.532.256 |
| Total Expenses - EUR | 4.953.938 | 5.914.830 | 7.305.660 | 8.809.937 | 10.898.578 | 11.760.290 | 16.643.004 | 18.709.677 | 21.297.295 | 24.490.393 |
| Gross Profit/Loss - EUR | -508.705 | -169.955 | 469.628 | 550.669 | 465.888 | 519.453 | 2.242.014 | 1.444.833 | 1.565.317 | 2.041.863 |
| Net Profit/Loss - EUR | -508.705 | -169.955 | 467.612 | 550.669 | 465.888 | 519.453 | 2.123.312 | 1.408.480 | 1.449.945 | 1.889.996 |
| Employees | 121 | 121 | 153 | 177 | 202 | 228 | 253 | 267 | 311 | 320 |
Check the financial reports for the company - Laboratoarele Bioclinica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.064.469 | 1.045.141 | 1.093.818 | 1.290.048 | 1.870.532 | 2.353.663 | 3.291.131 | 3.721.525 | 5.226.160 | 5.283.442 |
| Current Assets | 841.646 | 939.369 | 1.058.785 | 1.413.213 | 1.323.221 | 2.052.679 | 2.473.183 | 2.857.608 | 2.734.709 | 3.030.399 |
| Inventories | 169.613 | 197.728 | 223.770 | 362.545 | 362.198 | 452.701 | 683.648 | 673.803 | 651.725 | 675.242 |
| Receivables | 599.340 | 680.925 | 740.795 | 847.489 | 718.257 | 776.668 | 897.111 | 1.328.597 | 1.345.233 | 1.650.552 |
| Cash | 72.693 | 60.130 | 92.274 | 203.179 | 242.766 | 823.310 | 892.424 | 855.208 | 737.751 | 704.605 |
| Shareholders Funds | -4.785.085 | -2.679.464 | -2.159.768 | -1.569.463 | -1.073.181 | -533.383 | 1.601.757 | 3.015.207 | 4.456.008 | 6.321.101 |
| Social Capital | 1.125 | 2.227.888 | 1.095 | 1.074 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Debts | 6.767.482 | 4.729.560 | 4.357.097 | 4.305.296 | 4.303.528 | 4.980.339 | 4.108.551 | 3.514.265 | 3.660.846 | 2.098.581 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 9.451 | 5.175 | 798 | 454 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Laboratoarele Bioclinica Srl